Differential Neutralization of Unfractionated Heparin, Enoxaparin and Fondaparinux by Andexanet Alpha

被引：0
|
作者：
Fareed, Jawed
Walenga, Jeanine
Jeske, Walter
Bontekoe, Emily
Siddiqui, Fakiha
Kouta, Ahmed
Tafur, Alfonso
Hoppensteadt, Debra
机构：
来源：
FASEB JOURNAL | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
819.12
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Fondaparinux and enoxaparin in comparison to unfractionated heparin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model
    Schlitt, A
    Buerke, M
    Hauroeder, B
    Peetz, D
    Hundt, F
    Bickel, C
    Schaefer, I
    Meyer, J
    Rupprecht, HJ
    THROMBOSIS AND HAEMOSTASIS, 2003, 90 (02) : 245 - 251
  • [22] POEM - Fondaparinux is as effective and safe as unfractionated heparin for pulmonary embolism
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7439): : 532 - 532
  • [23] Consistent therapy with enoxaparin is superior to unfractionated heparin in SYNERGY
    Mahaffey, KW
    Califf, RM
    Cohen, M
    Pieper, KS
    White, HD
    Traylor, L
    Ferguson, JJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 231A - 231A
  • [24] Enoxaparin vs unfractionated heparin in acute coronary syndrome
    Kanna, B
    Sharma, P
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (16): : 1952 - 1952
  • [25] In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation
    Linkins, LA
    Julian, JA
    Rischke, J
    Hirsh, J
    Weitz, JI
    THROMBOSIS RESEARCH, 2002, 107 (05) : 241 - 244
  • [26] No clinically relevant interaction between sugammadex and heparin (enoxaparin and unfractionated heparin) on coagulation
    Kruithof, A.
    De Kam, P. J.
    El Galta, R.
    Moerland, M.
    Kluft, C.
    Van Lierop, M. J.
    Dennie, J.
    Troyer, M.
    Gutstein, D.
    Burggraaf, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1091 - 1092
  • [27] Intravenous enoxaparin versus unfractionated heparin in unselected patients undergoing percutaneous coronary interventions: the Zurich enoxaparin versus unfractionated heparin in PCI study (ZEUS)
    Bertel, Osmund
    Ramsay, David
    Wettstein, Tobias
    Kurz, David J.
    Stettler, Irene
    Straumann, Edwin
    Frielingsdorf, Juergen
    Maurer, Dominik
    Naegeli, Barbara
    EUROINTERVENTION, 2010, 6 (03) : 407 - 412
  • [28] Efficacy and safety of low molecular heparin (enoxaparin) compared with unfractionated heparin in hemodialysis
    不详
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2005, 28 (09): : 917 - 917
  • [29] Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention
    Montalescot, Gilles
    White, Harvey D.
    Gallo, Richard
    Cohen, Marc
    Steg, P. Gabriel
    Aylward, Philip E. G.
    Bode, Christoph
    Chiariello, Massimo
    King, Spencer B., III
    Harrington, Robert A.
    Desmet, Walter J.
    Macaya, Carlos
    Steinhubl, Steven R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (10): : 1006 - 1017
  • [30] Enoxaparin causes less bleeding than unfractionated heparin in PCI
    不详
    FORMULARY, 2005, 40 (11) : 402 - 402
12345